Evidence map›Paper›PMID 39248478›Full record

Trial reportMicrobiology spectrum2024

Changes in the pharyngeal and nasal microbiota in pediatric patients with adenotonsillar hypertrophy.

Federica Del Chierico, Antonia Piazzesi, Ersilia Vita Fiscarelli, Maria Vittoria Ristori, Ilaria Pirona, Alessandra Russo, Nicoletta Citerà, Gabriele Macari, Sara Santarsiero, Fabrizio Bianco and 5 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Federica Del ChiericoResearch Unit of Microbiome, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.ORCID 0000-0002-4204-4736
Antonia PiazzesiResearch Unit of Microbiome, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Ersilia Vita FiscarelliResearch Unit of Diagnostical and Management Innovations, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Maria Vittoria RistoriResearch Unit of Microbiome, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Ilaria PironaGenomeUp SRL, Rome, Italy.
Alessandra RussoUnit of Microbiomics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Nicoletta CiteràResearch Unit of Diagnostical and Management Innovations, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Gabriele MacariGenomeUp SRL, Rome, Italy.
Sara SantarsieroUnit of Otorhinolaryngology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Fabrizio BiancoQuality Team Studi Clinici, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Valeria AntenucciModelli Innovativi di Regolamentazione in Pediatria, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Valerio DamianiMedical Department, DMG Italia SRL, Pomezia, Italy.
Luigi MercuriMedical Department, DMG Italia SRL, Pomezia, Italy.
Giovanni Carlo De VincentisUnit of Otorhinolaryngology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Lorenza PutignaniUnit of Microbiomics and Research Unit of Microbiome, IRCCS, Bambino Gesù Children's Hospital, Rome, Italy.ORCID 0000-0003-0134-2830

Funding

Italian Ministry of Health Current Research funds
6 · The paper itself

Abstract

The present study aimed to investigate the pharyngeal and nasal microbiota composition in children with adenotonsillar hypertrophy (AH) and assess longitudinal alterations in both microbiota after a probiotic oral spray treatment. A cohort of 57 AH patients were enrolled and randomly assigned to the probiotic and placebo groups for a 5-month treatment course. Pharyngeal and nasal swabs were collected before and after treatment and analyzed by 16S rRNA-based metataxonomics and axenic cultures for pathobiont identification. 16S rRNA sequences from pharyngeal and nasal swabs of 65 healthy children (HC) were used as microbiota reference profiles. We found that the pharyngeal and nasal microbiota of AH children were similar. When compared to HC, we observed an increase of the genera IMPORTANCE: Adenotonsillar hypertrophy (AH) is considered the main cause of breathing disorders during sleep in children. AH patients, after significant morbidity and often multiple courses of antibiotics, often proceed to tonsillectomy and/or adenoidectomy. Given the potential risks associated with these procedures, there is a growing interest in the use of nonsurgical adjuvant therapies, such as probiotics, that could potentially reduce their need for surgical intervention. In this study, we investigated the pharyngeal and nasal microbiota in patients with AH compared with healthy children. Furthermore, we tested the effects of probiotic spray administration on both disease symptoms and microbiota profiles, to evaluate the possible use of this microbial therapy as an adjuvant for AH patients.

Indexed as

AdenoidsBacteriaHypertrophyMicrobiotaPalatine TonsilPharynxProbioticsRNA, Ribosomal, 16SChildChild, PreschoolFemaleHumansMaleNoseRespiratory Tract InfectionsRNA, Ribosomal, 16Sadenotonsillar hypertrophynasal microbiotapharyngeal microbiotaprobioticsupper airway pathobionts

Identifiers

PMID39248478
PMCPMC11449029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.